Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
27 /100
MEDIUM RISK
Score updated Oct 13, 2026

CGON — CG Oncology, Inc. Dilution Risk Tracker

Track CGON dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CGON — Get alerts when the score changes →

As of October 13, 2026, CG Oncology, Inc. (CGON) has a DilutionWatch DilutionScore of 27/100, rated MEDIUM dilution risk. CG Oncology, Inc. has a market capitalization of $5.60B, 88.64M shares outstanding, 239 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CGON.
🔔 Track CGON — Get forecast alerts →

Market Data

Market Cap$5.60B
Shares Outstanding88.64M
Float65.82M
Cash$1.03B
Debt$3.00M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore27/100DilutionWatch score record
Shares Outstanding88.64MVerified float table or market cache
Public Float65.82MVerified float table or market cache
Market Cap$5.60BMarket data cache
Cash Runway102.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 19.5% shares (2026Q1 vs prior)
239 institutional holders · 103.33M shares
#1 RTW INVESTMENTS, LP 6.98M shares
#2 T. Rowe Price Investment Management, Inc. 6.72M shares
#3 Decheng Capital LLC 6.37M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.44M
Days to Cover8.5
% of Float15.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-02-27
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CGON Dilution Snapshot

CG Oncology, Inc. (CGON) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CGON's DilutionScore is currently 27/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 17/100 (Low risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202627/100MEDIUM60 days
Jul 16 – Aug 13, 202617/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CGON shares outstanding have increased 6.8% from 82.62M (Mar 2026) to 88.20M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202688.20M65.82M▼ 9.59%
May 16, 202688.20M72.81M▲ 0.05%
May 12, 202688.20M72.77M▲ 4.46%
May 07, 202688.01M69.67M▲ 0.90%
Mar 20, 202684.44M69.04M▲ 4.35%
Mar 15, 202684.44M66.16M▼ 0.10%
Mar 10, 202684.44M66.23M▼ 0.15%
Mar 04, 202682.62M66.33M▲ 1.29%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CGON Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CGON files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CGON — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CGON
CGON FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.